Literature DB >> 15289784

Acute vanishing bile duct syndrome after ibuprofen therapy in a child.

M Taghian1, T A Tran, S Bresson-Hadni, A Menget, S Felix, E Jacquemin.   

Abstract

We report the case of a 10 year-old girl who had Stevens-Johnson syndrome and cholestasis after ibuprofen therapy. Liver histology was compatible with vanishing bile duct syndrome. She received ursodeoxycholic acid, and liver tests normalized within 7 months. This report confirms that ibuprofen may induce acute vanishing bile duct syndrome.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15289784     DOI： 10.1016/j.jpeds.2004.05.027

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

2.  Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.

Authors:  Ian Chong; Alice Chao
Journal:  Perm J       Date:  2017

3.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 4.  Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

Authors:  Jason C White; Stephanie Appleman
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

Review 5.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

6.  Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant.

Authors:  Hye-young Kim; Hea Kyoung Yang; Seong Heon Kim; Jae Hong Park
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

Review 7.  Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal.

Authors:  Maurizio de Martino; Alberto Chiarugi; Attilio Boner; Giovanni Montini; Gianluigi L De' Angelis
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

8.  Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.

Authors:  Wen Xie; Qi Wang; Yuanjiao Gao; Calvin Q Pan
Journal:  BMC Gastroenterol       Date:  2018-09-29       Impact factor: 3.067

9.  Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.

Authors:  Hyun Jeong Cho; Hye Jeong Jwa; Kyu Seon Kim; Dae Yong Gang; Jae Young Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.